comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 21:36:04 - browse：411

Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage — Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Wikipedia

WSS

A former Republican legislative candidate has been charged for his role in the US Capitol riot

FDA sets aggressive timeline for overhauling inspection procedures

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Reframing the conversation around gain

To bolster infectious disease surveillance, genomics powerhouses team up

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

hotspot

comprehensive

explore

Medicare details structure of new drug price negotiation program

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Hepatitis C has a cure — but many Americans still lack access to it

Dana Farber says 6 studies to be retracted and 31 corrected

Anesthesiologist group: stop taking Ozempic before surgery

TikTok, Instagram influencers need more rules for drug ads

FDA approval of Sarepta Duchenne genetic therapy gives me hope

It's time to take a new tack for treating Alzheimer's

Activists slam private health insurers over coverage restrictions

The inclusion problem at the heart of rehabilitation research

hotspot

The inclusion problem at the heart of rehabilitation research

Why Marc Tessier

The biotech scorecard for the 2nd quarter: 12 industry events to watch

What is the Turing Test that determines if computers can think?

Prosecutors say FTX founder Sam Bankman

Flu vaccine reformulation won't be easy, manufacturers warn

leisure time

focus

Wikipedia

entertainment